Overview

To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess bioequivalence between two products used for treatment of allergy.
Phase:
Phase 1
Details
Lead Sponsor:
McNeil AB
Treatments:
Cetirizine